Atea Pharmaceuticals, Inc. Common Stock AVIR
$5.07
+0.20%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $8.50
- Implied Upside
- +67.7%
- Price Target Range
- $7.00 – $10.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-13 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $6 → $7 |
| 2026-03-09 | Evercore ISI GroupJonathan Miller |
Maintains | Outperform | $6 → $10 |
| 2025-04-11 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $6 → $6 |
| 2024-08-13 | Morgan StanleyMatthew Harrison |
Upgrades | Underweight → Equal-weight | $2 → $7 |
| 2023-08-10 | JP MorganEric Joseph |
Downgrades | Neutral → Underweight | — |
| 2023-03-16 | JP MorganEric Joseph |
Maintains | Neutral | $12 → $8 |
| 2023-01-27 | SVB LeerinkRoanna Ruiz |
Maintains | Market perform | $8 → $6 |
| 2023-01-24 | Morgan StanleyMatthew Harrison |
Maintains | Underweight | $7 → $4 |
| 2022-08-15 | Morgan StanleyMatthew Harrison |
Maintains | Underweight | $6 → $7 |
| 2022-03-02 | JP MorganEric Joseph |
Maintains | Neutral | $10 → $8 |
| 2022-03-01 | SVB LeerinkRoanna Ruiz |
Maintains | Market perform | $10 → $9 |
| 2022-02-16 | SVB LeerinkRoanna Ruiz |
Maintains | Market perform | $11 → $10 |
| 2022-01-06 | Morgan StanleyMatthew Harrison |
Downgrades | Equal-weight → Underweight | $14 → $7 |
| 2021-11-18 | SVB LeerinkRoanna Ruiz |
Downgrades | Outperform → Market perform | $11 |
| 2021-10-20 | SVB LeerinkRoanna Ruiz |
Maintains | Outperform | $60 → $20 |
| 2021-10-20 | JP MorganEric Joseph |
Downgrades | Overweight → Neutral | $61 → $16 |
| 2021-10-05 | Morgan StanleyMatthew Harrison |
Downgrades | Overweight → Equal-weight | $55 |
| 2021-09-09 | SVB LeerinkRoanna Ruiz |
Initiates coverage on | Outperform | $60 |
| 2021-08-18 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $35 → $37 |
| 2021-06-03 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $82 → $35 |
| 2021-04-06 | Morgan StanleyMatthew Harrison |
Maintains | Overweight | $49 → $82 |
| 2021-01-29 | JP MorganEric Joseph |
Maintains | Overweight | $45 → $66 |
| 2020-11-25 | Evercore ISI Group |
Initiates coverage on | Outperform | — |
| 2020-11-24 | JP MorganEric Joseph |
Initiates coverage on | Overweight | $45 |
| 2020-11-24 | William BlairTim Lugo |
Initiates coverage on | Outperform | — |
| 2020-11-24 | Morgan StanleyMatthew Harrison |
Initiates coverage on | Overweight | $49 |
| 2017-02-15 | HC Wainwright & Co.Ed Arce |
Downgrades | Buy → Neutral | — |
| 2017-02-14 | Ladenburg Thalmann |
Downgrades | Buy → Neutral | — |
| 2016-09-21 | Ladenburg Thalmann |
Initiates coverage on | — | |
| 2016-07-13 | HC Wainwright & Co.Ed Arce |
Initiates coverage on | Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.07
- Market Cap
- $404.94 million
- 52-Week Range
- $2.78 – $6.45
- Average Volume
- 357K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.